ResearcherAcademy of Military Medical SciencesNo recent work listed

Fei-Jiao Ge

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5110427214. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2014: 1 paper

Papers 1

S-1 as monotherapy or in combination with leucovorin as second-line treatment in gemcitabine-refractory advanced pancreatic cancer: a randomized, open-label, m… Co-author DOI 10.1634/theoncologist.2014-0223 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Fei Li · 1 shared paper, 2014 · strength 0.04
- Paper S-1 as monotherapy or in combination with leucovorin as second-line treatment in gemcitabine-refractory advanced pancre… DOI 10.1634/theoncologist.2014-0223 ↗
Jianming Xu · 1 shared paper, 2014 · strength 0.04
- Paper S-1 as monotherapy or in combination with leucovorin as second-line treatment in gemcitabine-refractory advanced pancre… DOI 10.1634/theoncologist.2014-0223 ↗
Yanqiao Zhang · 1 shared paper, 2014 · strength 0.04
- Paper S-1 as monotherapy or in combination with leucovorin as second-line treatment in gemcitabine-refractory advanced pancre… DOI 10.1634/theoncologist.2014-0223 ↗
Yi Ba · 1 shared paper, 2014 · strength 0.04
- Paper S-1 as monotherapy or in combination with leucovorin as second-line treatment in gemcitabine-refractory advanced pancre… DOI 10.1634/theoncologist.2014-0223 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.